# A Study of Barzolvolimab in Patients With Prurigo Nodularis

> **NCT06366750** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Celldex Therapeutics** · enrollment: 140 (actual)

## Conditions studied

- Prurigo Nodularis

## Interventions

- **BIOLOGICAL:** barzolvolimab
- **OTHER:** Matching Placebo

## Key facts

- **NCT ID:** NCT06366750
- **Lead sponsor:** Celldex Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-12
- **Primary completion:** 2026-06
- **Final completion:** 2027-03
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06366750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06366750, "A Study of Barzolvolimab in Patients With Prurigo Nodularis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06366750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*